AT

Apollo Therapeutics

UK - Cambridge
Biotechnology4 H-1B visas (FY2023)

Focus: Antibodies, Fusion Proteins, Small Molecules, Vaccine

Apollo Therapeutics is a life sciences company focused on Antibodies, Fusion Proteins, Small Molecules, Vaccine.

Infectious DiseasesVaccines
Funding Stage
SERIES B
Employees
1-50
Total Funding
$260M
Open Jobs
0

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts
H-1B (2023): 4 approvals

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
4
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub